Researchers studied the potential harm of carbon nanoparticle absorption but found that lysosome encapsulation may prevent cell-damage from occurring.
Carbon nanoparticles are very promising tools for use in the delivery of therapeutic agents in the body and for bioimaging applications to monitor drug distribution and efficacy. These particles have been successfully attached to various therapeutic agents including small drug molecules, vaccines, immunotherapeutic agents, and gene therapies. Agents can be delivered directly into cell targets without first being metabolized. However, are there adverse effects that could potentially overshadow these benefits?